These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38205311)

  • 1. Executives' carbon cognition and corporate carbon performance: The mediating role of corporate low-carbon actions and the moderating role of firm size.
    Gao W; Wen S; Li H; Lyu X
    Heliyon; 2024 Jan; 10(1):e23959. PubMed ID: 38205311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family Sibling Effect and Executives' Corporate Social Behavior.
    Zheng M; Ren G; Zhuang L
    Front Psychol; 2021; 12():667529. PubMed ID: 34211422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Executives' ESG cognition and enterprise green innovation: Evidence based on executives' personal microblogs.
    Wang D; Luo Y; Hu S; Yang Q
    Front Psychol; 2022; 13():1053105. PubMed ID: 36544446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the impact mechanism of executives' environmental attention on corporate green transformation: evidence from the textual analysis of Chinese companies' management discussion and analysis.
    Ding X; Xu Z; Petrovskaya MV; Wu K; Ye L; Sun Y; Makarov VM
    Environ Sci Pollut Res Int; 2023 Jul; 30(31):76640-76659. PubMed ID: 37237116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Executive poverty experience and innovation performance: A study of moderating effects and influencing mechanism.
    Jia X; Wang T; Chen C
    Front Psychol; 2022; 13():946167. PubMed ID: 35978777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Executive pharmaceutical background, R&D investment and corporate innovation performance.
    Zhang L; Li S; Wu M
    Am J Transl Res; 2023; 15(11):6576-6586. PubMed ID: 38074834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Enterprises in China Achieve Sustainable Development through Green Investment?
    Zheng S; Jin S
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Returnee Executives, Corporate Social Responsibility, and Stock Price Synchronicity.
    Gao D; Zhao Y; Tian Q
    Front Psychol; 2022; 13():950436. PubMed ID: 35911051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do executives' backgrounds matter to IPO investors? Evidence from the life science industry.
    Chok J; Qian J
    PLoS One; 2013; 8(5):e60911. PubMed ID: 23690920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Returnee Executives Value Corporate Philanthropy? Evidence from China.
    Zhang L; Xu Y; Chen H
    J Bus Ethics; 2022; 179(2):411-430. PubMed ID: 34177016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship Between CEO Duality and Business Firms' Performance: The Moderating Role of Firm Size and Corporate Social Responsibility.
    Mubeen R; Han D; Abbas J; Álvarez-Otero S; Sial MS
    Front Psychol; 2021; 12():669715. PubMed ID: 35035363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corporate social responsibility, financing constraints, and corporate carbon intensity: new evidence from listed Chinese companies.
    Chen P
    Environ Sci Pollut Res Int; 2023 Mar; 30(14):40107-40115. PubMed ID: 36609966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Environmental Information Disclosure Enhance Firm Value?-An Analysis Based on Textual Characteristics of Annual Reports.
    Cai R; Lv T; Wang C; Liu N
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36901240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhance or inhibit? Unveiling the influence of chairman's hometown attachment on the corporate philanthropy-Corporate financial performance relationship.
    Chen L; Bu X
    Front Psychol; 2022; 13():956689. PubMed ID: 36438309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corporate social responsibility, internal control, and firm financial performance.
    Zhang L; Su W
    Front Psychol; 2022; 13():977996. PubMed ID: 36660285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental cooperation system, ESG performance and corporate green innovation: Empirical evidence from China.
    Qiang S; Gang C; Dawei H
    Front Psychol; 2023; 14():1096419. PubMed ID: 36935950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Transformational Leadership on Firm Performance: Mediating Effect of Corporate Sustainability and Moderating Effect of Knowledge-Sharing.
    Shahzad MA; Iqbal T; Jan N; Zahid M
    Front Psychol; 2022; 13():883224. PubMed ID: 35874334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do executives' synergistic allocation and organizational slack drive enterprise technological innovation?
    Bai G; Zhao J; Xu P
    PLoS One; 2022; 17(10):e0276022. PubMed ID: 36227881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Mediating Role of Responsible Innovation in the Relationship between Stakeholder Pressure and Corporate Sustainability Performance in Times of Crisis: Evidence from Selected Regions in China.
    Tian H; Tian J
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Executives' unethical behaviour with directions for future research.
    Zhu R; Li X; Liu Q; Zhou Q
    Front Psychol; 2022; 13():977130. PubMed ID: 36571063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.